Local vaccine production can earn Kenya billions of shillings each year in additional investments, savings and revenue, the Lancet medical journal says.
In a newly published study released recently, the journal has ranked Kenya a top candidate for vaccine manufacturing globally ahead of India and South Africa citing its strategic advantages in traditional research capacity as well as distribution logistics.
